Company Filing History:
Years Active: 1998
Title: The Innovations of David Oakley Clarke
Introduction
David Oakley Clarke is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of medicine, particularly in the treatment of benign prostatic hyperplasia. His innovative approach has led to the development of a unique method utilizing melatonin agonists.
Latest Patents
David Oakley Clarke holds 1 patent for his invention titled "Melatonin agonists for use in the treatment of benign prostatic hyperplasia." This patent outlines a method for treating this condition using various melatonin agonists, showcasing his commitment to advancing medical treatments.
Career Highlights
Clarke is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its research and development in innovative therapies. His work at Eli Lilly has allowed him to focus on groundbreaking research that addresses significant health issues.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including William Henry Jordan and Lisa A Shipley. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
David Oakley Clarke's contributions to the field of medicine through his patent and work at Eli Lilly and Company highlight his dedication to improving healthcare solutions. His innovative methods continue to pave the way for advancements in treatment options.